UREAPLASMA-UREALYTICUM CERVICAL COLONIZATION AS A MARKER FOR PREGNANCY COMPLICATIONS

被引:22
作者
HOROWITZ, S
HOROWITZ, J
MAZOR, M
PORATH, A
GLEZERMAN, M
机构
[1] SOROKA MED CTR KUPAT HOLIM,DEPT MED A,BEER SHEVA,ISRAEL
[2] BEN GURION UNIV NEGEV,FAC HLTH SCI,DEPT EPIDEMIOL,IL-84105 BEER SHEVA,ISRAEL
[3] SOROKA MED CTR KUPAT HOLIM,DEPT OBSTET & GYNECOL,BEER SHEVA,ISRAEL
关键词
UREAPLASMA UREALYTICUM; CERVIX; ANTIBODIES TO UREAPLASMA; PREGNANCY OUTCOME;
D O I
10.1016/0020-7292(94)02236-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To determine the clinical significance of cervical colonization with (Ureaplasma urealyticum (Uu) and its possible relationship to pregnancy outcome. Methods: Cervical cultures for Uu and serum antibodies to Uu were determined in four groups of pregnant women: (1) 117 women who underwent mid-trimester amniocentesis; (2) 47 women with preterm labor and intact membranes; (3) 34 women with preterm premature rupture of membranes; and (4) a control group of 315 healthy women with normal pregnancies. Statistical methods used were the chi-square and Fisher's exact tests. Results: A significant increase in the cervical colonization rate with Uu was detected in all study groups (62%, 77% and 74%, respectively) when compared with the control group (42%). Women at mid-trimester of pregnancy with a positive cervical culture and high levels of antibodies, had a higher rate of pregnancy complications than those with a negative culture and absence of antibodies (62 vs. 28%, respectively; P = 0.0006). Conclusion: Cervical colonization with Uu when associated with elevated titers of antibodies to Uu, may serve as a marker for the identification of a subpopulation of women who are at high risk for the development of pregnancy complications.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 25 条
[1]  
CAREY JC, 1991, AM J OBSTET GYNECOL, V164, P728
[2]   UREAPLASMA-UREALYTICUM INTRAUTERINE INFECTION - ROLE IN PREMATURITY AND DISEASE IN NEWBORNS [J].
CASSELL, GH ;
WAITES, KB ;
WATSON, HL ;
CROUSE, DT ;
HARASAWA, R .
CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (01) :69-87
[3]   A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ERYTHROMYCIN FOR THE TREATMENT OF UREAPLASMA-UREALYTICUM TO PREVENT PREMATURE DELIVERY [J].
ESCHENBACH, DA ;
NUGENT, RP ;
RAO, AV ;
COTCH, MF ;
GIBBS, RS ;
LIPSCOMB, KA ;
MARTIN, DH ;
PASTOREK, JG ;
RETTIG, PJ ;
CAREY, JC ;
REGAN, JA ;
GEROMANOS, KL ;
LEE, MLF ;
POOLE, WK ;
EDELMAN, R .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (03) :734-742
[4]   UREAPLASMA-UREALYTICUM AND PREMATURE BIRTH [J].
ESCHENBACH, DA .
CLINICAL INFECTIOUS DISEASES, 1993, 17 :S100-S106
[5]   ADVERSE OUTCOME IN PREGNANCY FOLLOWING AMNIOTIC-FLUID ISOLATION OF UREAPLASMA-UREALYTICUM [J].
GRAY, DJ ;
ROBINSON, HB ;
MALONE, J ;
THOMSON, RB .
PRENATAL DIAGNOSIS, 1992, 12 (02) :111-117
[6]   ERYTHROMYCIN [J].
GRIBBLE, MJ ;
CHOW, AW .
MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (01) :79-89
[7]   A CASE-CONTROL STUDY OF CHORIOAMNIONIC INFECTION AND HISTOLOGIC CHORIOAMNIONITIS IN PREMATURITY [J].
HILLIER, SL ;
MARTIUS, J ;
KROHN, M ;
KIVIAT, N ;
HOLMES, KK ;
ESCHENBACH, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (15) :972-978
[8]   RESPIRATORY-TRACT COLONIZATION WITH UREAPLASMA-UREALYTICUM AND BRONCHOPULMONARY DYSPLASIA IN NEONATES IN SOUTHERN ISRAEL [J].
HOROWITZ, S ;
LANDAU, D ;
SHINWELL, ES ;
ZMORA, E ;
DAGAN, R .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (10) :847-851
[9]  
HOROWITZ S, 1994, ISRAEL J MED SCI, V30, P450
[10]   ISOLATION AND PURIFICATION OF VIABLE UREAPLASMA-UREALYTICUM CELLS FREE FROM MEDIUM COMPONENTS [J].
HOROWITZ, S ;
GAL, H .
JOURNAL OF GENERAL MICROBIOLOGY, 1991, 137 :1087-1092